US Stock MarketDetailed Quotes
UCBB US-CHINA BIOMEDICAL TECHNOLOGY INC
- 0.000
- 0.0000.00%
15min DelayClose Aug 9 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)19.80MShares0.00052wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM4.16MShs Float0.350Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
US-CHINA BIOMEDICAL TECHNOLOGY INC Key Stats
Quarterly+Annual
YOY
| (Q1)May 31, 2019 | (FY)Feb 28, 2019 | (Q4)Feb 28, 2019 | (Q3)Nov 30, 2018 | (Q2)Aug 31, 2018 | (Q1)May 31, 2018 | (FY)Feb 28, 2018 | (Q4)Feb 28, 2018 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||
| Gross profit | ||||||||
| Operating expense | 41.12%122.2K | 1.27%522.06K | 48.45%173.15K | 119.35K | 142.97K | 86.59K | 515.52K | 116.64K |
| Selling and administrative expenses | 41.12%122.2K | 1.27%522.06K | 48.45%173.15K | --119.35K | --142.97K | --86.59K | --515.52K | --116.64K |
| -General and administrative expense | 41.12%122.2K | 1.27%522.06K | 48.45%173.15K | --119.35K | --142.97K | --86.59K | --515.52K | --116.64K |
| Operating profit | -41.12%-122.2K | -1.27%-522.06K | -48.45%-173.15K | -119.35K | -142.97K | -86.59K | -515.52K | -116.64K |
| Net non-operating interest income expense | 86.99%-507 | 63.44%-3.93K | 99.08%-29 | 0 | 0 | -3.9K | -10.74K | -3.15K |
| Non-operating interest expense | -86.99%507 | -63.44%3.93K | -99.08%29 | --0 | --0 | --3.9K | --10.74K | --3.15K |
| Other net income (expense) | -509.24%-184.16K | 0 | -184.16K | 45K | ||||
| Special income (charges) | --0 | -509.24%-184.16K | --0 | --0 | --0 | ---184.16K | --45K | --45K |
| -Less:Other special charges | ---- | 509.24%184.16K | --0 | ---- | ---- | --184.16K | ---45K | ---- |
| Income before tax | 55.32%-122.7K | -47.56%-710.14K | -131.55%-173.18K | -119.35K | -142.97K | -274.65K | -481.26K | -74.79K |
| Income tax | 0 | -11.70%800 | -11.70%800 | 0 | 0 | 0 | 906 | 906 |
| Net income | 55.32%-122.7K | -47.45%-710.94K | -129.84%-173.98K | -119.35K | -142.97K | -274.65K | -482.16K | -75.7K |
| Net income continuous Operations | 55.32%-122.7K | -47.45%-710.94K | -129.84%-173.98K | ---119.35K | ---142.97K | ---274.65K | ---482.16K | ---75.7K |
| Minority interest income | ||||||||
| Net income attributable to the parent company | 55.32%-122.7K | -47.45%-710.94K | -129.84%-173.98K | -119.35K | -142.97K | -274.65K | -482.16K | -75.7K |
| Preferred stock dividends | ||||||||
| Other preferred stock dividends | ||||||||
| Net income attributable to common stockholders | 55.32%-122.7K | -47.45%-710.94K | -129.84%-173.98K | -119.35K | -142.97K | -274.65K | -482.16K | -75.7K |
| Basic earnings per share | 50.00%-0.01 | -25.00%-0.05 | 0.00%-0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.01 |
| Diluted earnings per share | 50.00%-0.01 | -25.00%-0.05 | 0.00%-0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.01 |
| Dividend per share | ||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg